This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hollenberg, N. K. Articles by Harrington, D. P. Search for Related Content PubMed PubMed Citation Articles by Hollenberg, N. K. Articles by Harrington, D. P.

Hypertension, Vol 14, 9-13, Copyright © 1989 by American Heart Association

ARTICLES

Renal vasomotion in essential hypertension: influence of vasodilators

NK Hollenberg, T Sandor, E Holtzman, MF Meyerovitz and DP Harrington
Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115.

To assess factors responsible for phasic behavior of renal blood flow in essential hypertension, we applied an analytic method based on the estimation of power spectral density to xenon transit through the kidney and examined the renal vasodilator response to a range of agents in 53 normal subjects and 53 patients with essential hypertension. The renal vasodilator response to the calcium channel blocking agent diltiazem, but not the response to alpha-adrenergic blockade (phentolamine) or angiotensin converting enzyme inhibition (teprotide or captopril), was associated with a significant reduction in the amplitude of renal vasomotion. Acetylcholine, a vasodilator that acts through the release of a vasorelaxant factor or factors from endothelium, induced an unanticipated increase in renal vasomotion. These observations further dissociate factors responsible for basal renal vascular tone and periodic changes in renal vascular tone and raise the possibility that abnormalities in the flux of calcium into renal arterioles contribute to increased renal vasomotion in essential hypertension.

This article has been cited by other articles:

				J. L. Zhang, H. Rusinek, L. Bokacheva, R. P. Lim, Q. Chen, P. Storey, K. Prince, E. M. Hecht, D. C. Kim, and V. S. Lee Angiotensin-converting enzyme inhibitor-enhanced MR renography: repeated measures of GFR and RPF in hypertensive patients Am J Physiol Renal Physiol, April 1, 2009; 296(4): F884 - F891. [Abstract] [Full Text] [PDF]

				H. Nilsson and C. Aalkjaer Vasomotion: Mechanisms and Physiological Importance Mol. Interv., March 1, 2003; 3(2): 79 - 89. [Abstract] [Full Text] [PDF]

				L. O. Lerman and M. Rodriguez-Porcel Functional Assessment of the Circulation of the Single Kidney Hypertension, September 1, 2001; 38(3): 625 - 629. [Abstract] [Full Text] [PDF]